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Abstract
Background: People from lower socioeconomic groups have worse survival outcomes for cancer, which in part
reflects later-stage disease at diagnosis. The mechanisms underlying delayed cancer symptom presentation in lower
socioeconomic groups are not well understood.
Methods: Systematic review of studies of actual or anticipated symptom presentation across all tumour sites.
Included studies measured socioeconomic group, symptom presentation and one or more of the following
variables: cancer symptom knowledge, beliefs about cancer, barriers/facilitators to symptom presentation.
Results: A total of 60 studies was included. Symptom knowledge overall was lowest and actual presentation time
was longest in lower socioeconomic groups. Knowledge for specific symptoms such as lumps and bleeding was
good and encouraged timely symptom presentation, in contrast to non-specific symptoms which were not well
recognised. The combination of fearful and fatalistic beliefs was typically associated with later presentation,
especially in lower socioeconomic groups. Emotional barriers such as ‘worry what the doctor might find’ were more
frequently reported in lower socioeconomic groups, and there was evidence to suggest that disclosing symptoms
to family/friends could help or hinder early presentation.
Conclusions: Poor symptom knowledge, fearful and fatalistic beliefs about cancer, and emotional barriers combine
to prolong symptom presentation among lower socioeconomic groups. Targeted interventions should utilise social
networks to improve knowledge of non-specific symptoms, challenge negative beliefs and encourage help-seeking,
in order to reduce avoidable delays and minimise socioeconomic group inequalities.
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Background
Socioeconomic inequalities in cancer survival out-
comes exist, but the reasons for this are not fully
understood [1–3]. Survival differences are likely to
reflect later-stage disease at diagnosis [2, 4, 5] partly as a
consequence of delayed cancer symptom presentation in
people from lower socioeconomic groups [6]. By eradicat-
ing socioeconomic inequalities at stage of diagnosis, it is
estimated that 5600 patients in the UK annually could be
diagnosed with earlier stage disease [7], and that 11 % of
deaths from cancer could be avoided if three-year survival
in lower socioeconomic groups matched that in higher
socioeconomic groups [1].
‘Patient delay’ is defined as the time between discovery
of a cancer symptom and the initial visit to a healthcare
professional. It accounts for the greatest proportion of
delay time in the pathway from symptom discovery to
the start of cancer treatment [8–10] and has been
associated with socioeconomic deprivation [6]. Patient
delay has been conceptualised in Walter et al.’s Model
of Pathways to Treatment, with various stages involv-
ing an ‘appraisal interval’ during which the individual
detects a bodily change, and a ‘help seeking interval’
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in which the individual decides to seek medical help
(see Fig. 1 [11]). Evidence suggests that knowledge of
cancer symptoms is important during the appraisal
stage, with potential misattribution of symptoms
attenuating the decision to present [12, 13]. Beliefs
about cancer are considered to be important in both
the appraisal and help-seeking stages, where emotions
such as fear might influence interpretation of symp-
toms [12] and the decision to seek medical help [6,
14–17]. Barriers such as competing life events and
ease of getting a medical appointment are thought to
delay symptom presentation during the help-seeking
interval [11].
The contribution of socioeconomic and other demo-
graphic factors to delayed presentation has been
highlighted in the Model of Pathways to Treatment, and
more recently in the updated National Awareness and
Early Diagnosis Initiative (NAEDI) framework designed
to conceptualise the route from public awareness and
beliefs about cancer to cancer survival outcomes ([18]).
Empirical evidence supports associations between
lower socioeconomic group and poor cancer symptom
knowledge [19], fearful and fatalistic beliefs about
cancer [20] and emotional barriers such as worry
about what the doctor may find [19]. These findings
help to explain why people from lower socioeconomic
groups tend to present with more advanced stage cancers,
and hence have worse survival outcomes [1–5]. However,
a more detailed understanding of psychosocial influences
on the relationship between socioeconomic deprivation
and cancer symptom presentation is essential to develop-
ing behavioural interventions designed to promote timely
presentation and reduce socioeconomic inequalities in
cancer outcomes.
Attempts to understand why people might delay seek-
ing medical help for cancer symptoms have examined
actual or anticipated symptom presentation behaviour,
exploring perceived barriers to symptom presentation.
Prospective study designs are difficult due to follow-up
of a large sample, so studies frequently use retrospect-
ively recalled or hypothetically anticipated symptom
study designs. Previous reviews have focused on tumour
site-specific delay factors [15, 16, 21] or common
cancers only [6], or have been restricted to qualitative
studies [17] and patients with cancer [6, 16, 17]. The
purpose of the current systematic review was to explore
how knowledge, beliefs and barriers/facilitators to symp-
tom presentation affect actual or anticipated cancer
symptom presentation in relation to socioeconomic
group and across all tumour sites.
Fig. 1 Model of pathways to treatment. Produced with permission of SAGE Publications Ltd., London, Los Angeles, New Delhi, Singapore and
Washington DC, from Walter FM, Scott SE, Webster A, Emery JD. ‘The Andersen Model of Total Patient Delay: a systematic review of its application
in cancer diagnosis’. J Health Services Research & Policy (© Walter, 2012)
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Method
Identification of included studies followed the PRISMA
guidelines [22]. The protocol was registered on
PROSPERO (CRD42014013220 [23]) and is available
on the NIHR HTA programme website (www.hta.ac.uk).
At all stages of the search, data extraction and quality
appraisal, 10 % of studies were double checked for
consistency by a second member of the research team
(RR). All discrepancies were resolved through discussion.
Search strategy
The literature was searched up to July 2015 on the elec-
tronic databases of MEDLINE, PsychINFO, EMBASE
and CINAHL. The de-duplicate function was used on
Ovid and CINAHL before reviewing abstracts. Manual
searches of reference lists of included studies were
performed. A SPIDER (Sample, Phenomenon of Interest,
Design, Evaluation, Research type) search strategy tool
was used for retrieval of studies (see Additional file 1:
Appendix 1 [24]). Databases were searched using terms
relating to symptom presentation, cancer symptom know-
ledge, beliefs about cancer, perceived barriers and facili-
tators to symptom presentation (see Additional file 1:
Appendix 1).
Inclusion criteria
Publications that measured and reported data for
symptom presentation and socioeconomic group were
included. ‘Symptom presentation’ was defined as ac-
tual symptom presentation (retrospectively recalled)
or anticipated symptom presentation (hypothetically
estimated) measured as continuous (time to presentation)
or binary (did/did not present) variables. ‘Socio-
economic group’ was defined in terms of individual
level socioeconomic indicators including education,
income, home/car ownership, occupation and employ-
ment, and/or area-level indicators based on postcode.
In addition, publications were included if they mea-
sured and reported one or more of the following do-
mains of interest:
 ‘Knowledge’: studies which assessed knowledge for
the symptoms of cancer through recall e.g. ‘What
symptoms of cancer can you list?’ or recognition
methods e.g. ‘Which of these are symptoms of
cancer?’, or through retrospective recall of symptom
interpretation at the time of symptom discovery.
 ‘Beliefs’: studies which explored any positive
(e.g. beliefs about the benefits of early diagnosis
and curability) or negative (e.g. fear and fatalism)
beliefs surrounding cancer.
 ‘Perceived barriers/facilitators’: studies which
assessed any anticipated or actual barriers or
facilitators to symptom presentation.
There were no restrictions on date of publication or
study methodology. Only English language studies from
high income countries as classified by Organisation for
Economic Co-operation and Development (OECD)
membership (OECD, 2014 [25]) were included.
Exclusion criteria
Studies that did not measure and report symptom presen-
tation, socioeconomic group and one or more of the
domains of interest were excluded. Studies not relating to
cancer, and those examining screening behaviour, self-
examination behaviour, efficacy of interventions, genetic
risk, healthcare professionals’ perspective, cancer preven-
tion, treatments for cancer or living with cancer and studies
involving children were excluded. Studies from low/middle
income countries, not written in English, review papers or
conference abstracts were excluded (Fig. 2).
Data extraction and synthesis
Data were extracted onto a template using the following
headings: method, sample characteristics, tumour site,
symptom presentation, knowledge, beliefs, perceived
barriers/facilitators and socioeconomic group measure.
A meta-analysis was precluded due to the heterogeneity
of included studies and a narrative synthesis was per-
formed [26].
Critical appraisal
The methodological quality of all included studies was
examined using the Critical Appraisal Skills Programme
tool (CASP, 2014 [27]) appropriate for the study design.
Quality was assessed according to each domain on the
CASP checklists: rationale of study, methodology,
design, recruitment, data collection, data analysis, ethical
issues, reporting of findings and contribution to re-
search. Overall quality was categorised as good, medium
or poor.
Results
The search returned a total of 1536 studies after 810
duplicates had been removed. A total of 1309 studies
was excluded based on title and abstract, leaving 227
studies to be read in full. A total of 60 studies met the
inclusion criteria (see Fig. 2). Eleven of these studies
were found through hand searching reference lists.
Included studies employed qualitative methods (n = 15),
quantitative methods (n = 42) and mixed methods (n = 3).
Quality of studies was good (n = 18), medium (n = 37) and
poor (n = 5). Limitations of lower quality studies included
measuring but not reporting socioeconomic group differ-
ences for all outcome measures, leaving a long period of
time between cancer diagnosis and participation in the
study and recruitment of samples biased towards higher
socioeconomic groups. The overall combined percentage
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agreement between raters (GM and RR) for inclusion/
exclusion of studies, critical appraisal and data extrac-
tion was 87 %.
A total of 53 studies examined time to symptom pres-
entation, seven studies reported presentation behaviour
(if participants did or did not present or anticipate
presenting to their doctor with reported symptoms),
45 studies measured actual symptom presentation, 15
studied anticipated symptom presentation, 46 studies
assessed knowledge for cancer symptoms, 32 studies
explored beliefs about cancer and 50 studies exam-
ined perceived barriers/facilitators to symptom pres-
entation. The numbers of studies by tumour site were
as follows: breast (n = 22), any cancer/multiple tumour
sites (n = 15), colorectal (n = 7), skin (n = 6), oral and
pharyngeal (n = 3), ovarian (n = 3), lung (n = 2), gynae-
cological (n = 1), and prostate (n = 1) (see Table 1).
Results are presented according to domain headings.
Symptom presentation
Studies involving anticipated symptom presentation re-
ported shorter time to symptom presentation compared
with studies that examined actual time to symptom
presentation. In the former, most participants antici-
pated seeking medical help within one week [28–30] or
within one month [19, 31, 32], in contrast to real-world
studies where it was more common for patients to have
waited over two months before seeking medical help
[33–41]. The most prompt actual and anticipated symp-
tom presentation was reported for lumps [32, 38, 42–47]
or bleeding [19, 32, 48–53]. Studies examining partici-
pants who reported experiencing a potential symptom of
cancer in the past three months found between 59 %
and 75 % of participants had consulted a doctor about
their symptom [49, 54, 55].
Disparity between actual and anticipated symptom
presentation relating to socioeconomic group was
observed. In five studies, shorter anticipated time to
symptom presentation was observed in lower compared
to higher socioeconomic groups [19, 28, 31, 32, 48].
Conversely, in two studies, longer anticipated time to
symptom presentation was reported in those from lower
socioeconomic groups compared with higher socioeco-
nomic groups [56, 57].
Fig. 2 PRISMA flow diagram. Produced using a downloadable template available at http://www.prisma-statement.org/ (Moher et al,
2009 [22])
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Table 1 Table of included studies
Study Method Sample Country Tumour
site
Socio-
economic
measure
Measures: Knowledge (K),
Beliefs (B), Perceived barriers
(PB), Perceived facilitators
(PF), Symptomatic
Presentation (SP)
Measure of association
between variables of interest
and socioeconomic indicator
(qualitative studies not
applicable)
Quality appraisal
Brain et al. (2014) [28] Hypothetical
Quantitative
1043 women.
Aged 50 years
and over
Wales Ovarian Postcode,
education
K: Recognition (mean, 6.85
symptoms)
B: Cancer worry
PB: Emotional and practical
barriers
SP: Sought medical help in
under 3 weeks
(n = 898)
K: Lower education
associated with lower
knowledge (F(2, 1005) = 8.23,
p < 0.001); higher deprivation
(postcode) associated with
lower knowledge (F3,886 = 2.82,
p < 0.05)
B: NR
PB: NR
SP: Higher education
associated with longer time to
SP, (OR = 2.64, p≤ 0.001); NS
difference between
deprivation by postcode and
anticipated delay (X2(3) = 6.73,
p > 0.05) NS
Good
Brouha et al. (2005) [76] Retrospective
Quantitative
189 men and
women. Mean
age: 59 years
Holland Oral and
Pharyngeal
Education,
income
K: Symptom interpretation
(‘cancer’, n = 2), misattribution
of symptoms to dental
problems delayed SP
PB: Symptom did not
interfere with daily life
PF: Persistence of symptom,
development of new
symptom
SP: Mean time to symptom
presentation (pharyngeal,
45 days; oral, 28 days)
K: NR
PB: NR
PF: NR
SP: Education and income
not associated with time to
SP (statistics NR)
Medium
Burgess et al. (1998) [45] Retrospective
Qualitative
185 women. Mean
age: 54 years
UK Breast Occupation K: Symptom interpretation
(46 % thought their symptom
indicated cancer)
B: Fear
PF: Symptom disclosure,
appearance of new
symptoms, appointment
booked with GP for another
reason
SP: Waited over 3 months to
seek medical help (19 %)
Medium
Burgess et al. (2000) [67] Retrospective
Qualitative
158 women. Mean
age: 53 years
UK Breast Occupation PB: Life events
SP: Waited over 3 months to
seek medical help (18 %)
Medium
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Table 1 Table of included studies (Continued)
Burgess et al. (2001) [43] Retrospective
Qualitative
46 women. Mean
age: 54.1 years
UK Breast Occupation K: Symptom interpretation
(‘lump’ most attributed to
cancer)
B: Consequences of
treatment
PB: Not wanting to bother
the doctor, poor health
service utilisation, competing
life priorities
PF: Symptom disclosure,
change in symptom
SP: Waited over 3 months to
seek medical help (n = 31)
Medium
Cameron and Hinton
(1968) [58]
Retrospective
Quantitative
83 women UK Breast Education,
husband’s
occupation
K: Symptom interpretation
B: Fear, worry
SP: 61 % sought medical help
within 1 month
K: NR
B: NR
SP: Higher education
associated with shortest time
to SP for lump symptoms
(x2 = 6.6, p < 0.05); Higher
social group (husband’s
occupation) associated with
shortest time to SP (x2 = 3.02,
p < 0.01)
Poor
Caplan (1995) [44] Retrospective
Quantitative
162 women US Breast Income,
education,
employment
PB: Fluctuating symptoms,
relationship with GP
SP: Waited over 2 months to
seek medical help (n = 27)
PB: NR
SP: Lower socioeconomic
group (various indices)
associated with longer time
to SP, but NS: High vs low
income (OR 2.56, 95 % CI:
0.68-8.64*); High vs low
education (OR 1.07, 95 % CI:
0.41-2.77*); Working vs non-
working (OR 0.72, 95 % CI:
0.27-1.99*)
Poor
Carter-Harris et al. (2015) [69] Retrospective
Qualitative
11 men (n = 4)
and women
(n = 7). Age range:
40-76 years
US Lung Education,
employment
K: Symptom interpretations
(one participant was alarmed
at symptoms)
PB: Vague and intermittent
nature of symptoms
PF: Worsening of symptoms,
good relationship with GP
SP: Immediate (n = 1)
Medium
Chonjnacka-Szawlowska
et al. (2013) [36]
Retrospective
Quantitative
301 men (n = 186)
and women
(n = 115). Mean
age: 42.3 years
Poland All Education K: Recall, mean: 1.51
B: Fatalism and cancer
curability
SP: Mean time to symptom
presentation: 6 months and
10 days; stage of cancer
K: NR
B: NR
SP: NS correlation between
education and stage of
cancer (statistics NR)
Medium
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Table 1 Table of included studies (Continued)
Coates et al. (1992) [42] Retrospective
Quantitative
735 women
(410 black and
325 white). Age
range: 20 to 79
US Breast Education,
occupation,
poverty index
(income/no of
people in
household)
K: Symptom interpretation
B: Fatalism
PB: Symptom disclosure,
other comorbid conditions,
appointment with doctor
booked for another reason
SP: Median time to symptom
presentation (black women,
16 days; white women,
14 days)
K: NR
B: NR
PB: NR
SP: Higher education
associated with shorter time
to SP (Mantel-cox 1.43, 95 %
CI: 1.11-1.86, p < 0.05); Low
deprivation (poverty index)
associated with shorter time
to SP (Mantel-Cox 1.24, 95 %
CI: 1-1.54, p < 0.05)
Good
Cockburn et al. (2003) [54] Retrospective
Quantitative
1332 men (40 %)
and women (60 %).
Aged 40 years
and over
Australia Colorectal
(Bowel)
Education K: Recall (25 % could
not recall any symptoms),
symptom interpretation
B: Benefits of early diagnosis
SP: 306 had experienced a
symptom, 31.9 % did not
seek medical help
K: Higher education
associated with higher K of
symptoms (PR 0.93, 95 % CI:
0.89-0.96*)
B: Higher education more
likely to hold positive beliefs
about the benefits of early
diagnosis (statistics NR)
SP: NR
Medium
Esteva et al. (2013) [70] Retrospective
Quantitative
795 men (n = 489)
and women
(n = 291)
Spain Colorectal Social class,
education
K: Symptom interpretation
(‘not serious’, 65.6 %)
PF: Symptom disclosure,
good relationship with
GP (trust)
SP: Median time to symptom
presentation (19 days)
K: NR
SP: NS association between
social class and time to SP
(statistics NR), NS association
between education and time
to SP (statistics NR)
Medium
Facione and Facione
(2006) [59]
Retrospective
Qualitative
28 women. Mean
age: 42.34 years
US Breast Income,
education,
health
insurance
K: Symptom interpretation
B: Fear, fatalism, benefits of
early diagnosis
PB: Worry about losing
relationship with partner if
diagnosed with cancer
PF: Symptom disclosure
SP: Sought medical help after
3 months (n = 15)
Medium
Facione et al. (2002) [56] Hypothetical
Quantitative
669 women. Mean
age: 46.95 years
US Breast Income,
education,
health care
insurance
K: Recognition (10 %
recognised all or all but one
symptoms)
B: Fatalism
PB: Difficulties with access,
prejudice in health care,
concerns about deportation,
use of alternative therapies
SP: Likely to delay (23.7 %).
K: Higher education
associated with higher
symptom recognition
(F3,690 = 32.32, p < 0.001)
B: NR
PB: NR
SP: Lack of insurance
associated with longer time
to SP (Cramer’s V = 0.187,
p < 0.001); Lower education
associated with longer time
to SP (Cramer’s V = 0.288,
p < 0.001); Lower income
Good
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Table 1 Table of included studies (Continued)
associated with longer time
to SP (Cramer’s V = 0.291,
p < 0.001)
Facione et al. (1997) [84] Hypothetical
Quantitative
352 African
American or Black
women. Mean
age: 38.6 years
US Breast Income,
Education,
Employment
B: Fear, fatalism
PB: Poor health service
utilization
SP: 11.6 % = strong
disposition to SP.
B: NR
PB: NR
SP: Stronger disposition to SP
associated with lower
education (r = 0.19, p < 0.01)
and lower income (r = 0.32,
p < 0.001)
Medium
Facione and Dodd (1995) [83] Retrospective
Qualitative
39 women. Mean
age: 49.6 years
US Breast Income,
education
K: Symptom interpretation
B: Fear
PB: Competing life priorities
PF: Appearance of new
symptom, worsening of
symptoms, symptom
disclosure
SP: 59 % sought medical help
within 1 week
Medium
Fitzpatrick et al. (1998) [57] Hypothetical
Quantitative
280 men. Mean
age: 53.7 years
Ireland Prostate Health
insurance,
occupation
B: Fear
PB: Poor health service
utilisation, dislike of doctors,
embarrassment
SP: 81 % would seek medical
help if developed urinary
symptoms
B: NR
PB: NR
SP: Non-manual social class
associated with higher
willingness to attend GP with
symptoms (OR 1.8, p < 0.05**)
Good
Forbes et al. (2011) [29] Hypothetical
Quantitative
1515 women from
various ethnic
groups (White,
South Asian,
Black). Aged 30
years and over
UK Breast Postcode
(IMD)
K: Recognition (18 %
recognised 5 or more
non-lump symptoms)
PB: self-efficacy, worry what
the doctor might find,
embarrassment, worry
about wasting doctors
time, difficulty getting an
appointment
SP: 73 % would seek help
within 1 week
K: Differences between ethnic
groups for cancer awareness
not due to IMD score or
lower level of education
(statistics NR)
PB: Differences between
ethnic groups for PB not due
to IMD score (statistics NR)
SP: NR
Good
Forbes et al. (2014) [64] Retrospective
Quantitative
1999 men (n =
1077) and women
(n = 922). Aged 50
or over
UK All Postcode K: Symptom interpretation
PB: 48 % of patients reported
at least one barrier
SP: Delay over 3 months
(n = 21 %)
B: NR
PB: NR
SP: Lowest socioeconomic
group associated with
longest time to SP (1.51,
95 % CI: 1.18-1.88*)
Good
Freidman et al. (2006) [38] Retrospective
Quantitative
124 women. Mean
age: 44.3 years
US Breast Employment,
education
B: Fear
PB: Worry what the symptom
might be, difficulty getting
an appointment, cost, denial
B: NR
PB: NR
SP: Lower education
associated with longest time
Medium
M
cC
utchan
et
al.BM
C
Cancer
 (2015) 15:1000 
Page
8
of
23
Table 1 Table of included studies (Continued)
SP: Mean time to symptom
presentation (9 months)
to SP (Fishers Exact test,
p < 0.01**)
Goldsen et al. (1957) [61] Retrospective
Quantitative
727 men and
women
US All Income,
education and
occupation
K: Symptom interpretation
(20 % thought symptoms
indicated cancer)
B: Cancer worry, fatalism
PB: Poor health service
utilization, symptom not
noticed
PF: Symptom disclosure
SP: 51.3 % sought medical
help under 30 days
K: NR
B: NR
PB: NR
PF: NR
SP: Lower income, education
and occupation associated
with longest time to SP
(statistics NR)
Medium
Gould et al. (2010) [39] Retrospective
Qualitative
14 women. Aged
range: 30 to 69
years
Canada Breast Education,
employment,
income
K: Symptom interpretation
(poor for non-lump
symptoms)
B: Fear
PB: Previous benign disease,
watchful waiting, competing
life priorities
PF: Symptom disclosure,
already have another
appointment booked.
SP: All women waited
8+ weeks
Medium
Grant et al. (2010) [82] Retrospective
Qualitative
15 men (n = 7)
and women
(n = 8). Aged 45
years and under
Scotland Oral Postcode K: Symptom interpretation
PB: Self-medication
PF: Already had an
appointment booked
SP: Sought medical help
within 8 weeks (n = 8)
Medium
Greer (1974) [68] Retrospective
Quantitative
160 women with
stage I or stage II
cancer. Aged 70
years and under
UK Breast Social Class K: Symptom interpretation
B: Fear, fatalism
PB: Embarrassment
SP: 64 % sought medical
help within 1 month
K: NR
B: NR
PB: NR
SP: NS difference between
time to SP and social class
(statistics NR)
Poor
Hunter et al. (2003) [30] Hypothetical
Quantitative
546 women. Mean
age: 47 years
UK Breast Occupation K: Recognition (good,
mean 6.65)B: Beliefs about
treatment
SP: 58.6 % would seek
immediate medical help.
K: NR
NR: NR
SP: Socioeconomic group not
associated with time to SP
(F(1,518) = 0.29, p > 0.05)
Medium
Kakagia et al. (2013) [34] Retrospective
Quantitative
513 men
(n = 56.5 %) and
women
(n = 43.5 %).
Mean age: 67.5
years
Greece Skin Education,
ethnicity, area
of residence
K: Symptom interpretation
B: Fear, fatalism
PB: Other serious
comorbidities, poor health
service utilisation, dislike of
doctors and hospitals,
transport issues, worry about
K: NR
B: NR
PB: NR
PF: NR
SP: Longer time to SP
associated with lower
socioeconomic group
Medium
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Table 1 Table of included studies (Continued)
wasting doctors time,
embarrassment, competing
life demands
PF: Symptom disclosure,
active encouragement to
seek medical help
SP: Mean time to symptom
presentation (3.9 months)
(OR 1.89, 95 % CI: 0.9-3.8.
p < 0.001) and lower
education (OR 3.01, 95 % CI:
1.6-5.6, p < 0.001)
Lam et al. (2009) [63] Retrospective
Qualitative
37 women. Age
range 20-81 years
Hong Kong Breast Employment,
education
K: Symptom interpretation
B: fear, fatalism
PB: Watchful waiting, poor
general health service
utilisation, cost, competing
life priorities, embarrassment
PF: Persistence of symptoms,
appearance of new
symptom, symptom
disclosure, symptom
interfering with daily life,
appointment booked for
another reason
SP: Waited over 3 months to
seek medical help (n = 14)
Medium
Li et al. (2012) [65] Retrospective
Quantitative
425 women. Mean
age: 51.97 years
Hong Kong Breast Employment,
education
B: Fear
PB: Cost, gender of doctor,
unsure where to seek
medical help, competing life
priorities, no history of breast
problems, symptom
disclosure
PF: Symptom disclosure
SP: Median time to symptom
presentation (14 days)
B: NR
PB: Symptom disclosure for
women with lower education
less likely to translate into
immediate SP (x2 = 6.4,
d.f. = 2, p < 0.05)
PF: NR
SP: Longer time to SP
associated with higher
education (OR 3.35, 95 %
CI:1.19-9.42, p < 0.05) and full
time employment (OR 2.52,
95 % CI: 1.18-5.36, p < 0.05)
Good
Loehrer et al. (1991) [71] Retrospective
Qualitative
128 men (n = 33)
and women
(n = 95). Mean
age: 63 years
US All Employment,
income,
education
B: Curability of cancer, cancer
is contagious, surgery causes
cancer to spread
SP: Poor for non-specific
symptoms
Medium
Low et al. (2013) [31] Hypothetical
Quantitative
1000 women.
Mean age:
47 years
UK Ovarian Education, car
ownership,
home
ownership
K: Recall (poor, mean 0.6) and
recognition (good, mean 6.3)
PB: Mean number of barriers
endorsed (2.2), emotional,
practical and service barriers
SP: Varied by symptom, most
K: NR
PB: NR
SP: Higher socioeconomic
group associated with longer
time to SP (beta = 0.12, SE
0.05, p < 0.001**)
Good
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Table 1 Table of included studies (Continued)
would seek help under 2
weeks
Magarey et al. (1977) [72] Retrospective
Quantitative
64 women. Age in
years: less than 40
(n = 13), 40-60
(n = 28), over 60
(n = 23).
Australia Breast Education PB: Denial, anxiety
SP: Most sought medical help
within 2 weeks (n = 35)
PB: NR
SP: Education not associated
with time to SP (statistics NR)
Poor
Marlow et al. (2014) [78] Hypothetical
Qualitative
54 women from
ethnic minority
groups living with
a comparison of
white women.
Age range: 25-64
years
UK Breast and
Ovarian
Employment,
education,
living
arrangement
K: Recall (good for lumps/
bleeding, poor for other
symptoms)
B: Fear, fatalism, benefits of
early diagnosis
PB: Poor relationship with GP,
emotional barriers, practical
barriers, service barriers,
competing life priorities
PF: Symptom disclosure
SP: Varied: days to months.
All sought help within
3 months.
Medium
McCaffery et al. (2003) [50] Hypothetical
Quantitative
1637 men
(n = 763) and
women (n = 874).
Age range: 16-74
years
UK Colorectal Education K: Recall (poor)
B: Fear
SP: 92.8 % would anticipate
seeking medical help if
noticed blood in stool for
more than 2 weeks.
K: Higher education
associated with higher
symptom recall (x2 [4] = 73.98,
p < 0.001)
B: Lower education
associated with most
negative beliefs (x2 [4] =
74.96, p < 0.001)
SP: NS association with
education and SP intentions
(statistics NR)
Good
Meechan et al. (2003) [46] Retrospective
Mixed
85 women. Mean
age: 38.9 years
New Zealand Breast Education PB: Having a family member
with cancer, low emotional
response to symptom
PF: High emotional response
to symptom
SP: Median time to symptom
presentation
(14 days)
PB: NR
PF: NR
SP: NS association between
education and time to SP (t
(83) = -1.26, p > 0.05)
Medium
Mor (1990) [74] Retrospective
Mixed
700 patients. Age
range: 45 to 90
years
US Lung,
Breast and
Colorectal
Education,
housing,
income,
education
K: Symptom interpretation
(best knowledge for breast
cancer patients)
B: Fear (16.8 % of delayers)
PB: ‘’thought it would go
away” (60.5 % of delayers),
too busy (8.4 % of delayers)
K: NR
B: NR
PB: NR
SP: NS relationship between
socioeconomic group and
time to SP (statistics NR)
Medium
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Table 1 Table of included studies (Continued)
SP: Waited over 3 months to
seek medical help: lung
(54.9 %), breast (56.2 %),
colorectal (87.6 %)
Oliveria et al. (1999) [37] Retrospective
Quantitative
255 men and
women. Aged 18
years and over
US Melanoma Education,
insurance
K: Recognition (poor)
SP: Mean time to symptom
presentation (2 months)
K: NR
SP: Education not associated
with time to SP (statistics NR)
Medium
O’Mahony and Hegarty
(2009) [47]
Retrospective
Quantitative
99 women. Mean
age: 40 years
Ireland Breast Employment,
education
K: Symptom interpretation
PB: Competing life priorities,
emotional reactions to
symptom (afraid, scared,
unsure)
PF: Symptom disclosure,
anxiety
SP: Waited over 1 month to
seek medical help (n = 26)
K: NR
PB: NR
PF: NR
SP: Higher education
associated with longer time
to SP (statistics NR)
Medium
O’Mahony et al. (2011) [79] Retrospective
Qualitative
10 women. Mean
age: 40 years
Ireland Breast Education,
employment,
insurance
K: Most aware that a lump
was a symptomof cancer
B: Fatalism, curability of
cancer, fear
PB: Denial, competing life
priorities
PF: Symptom disclosure,
good perceived access to GP,
good relationship with GP
SP: Sought medical help
within 1 month (n = 6)
Medium
Pedersen et al. (2011) [85] Retrospective
Quantitative
901 men (n = 423)
and women
(n = 487). Mean
age: 61.8 years
Denmark All Education PF: Symptom disclosure,
good partner support
SP: Median interval: 12 days
PF: NR
SP: NS association between
education and time to SP:
Lower secondary education
and long SP (>55 days) (RRR
0.79, 95 % CI: 0.36-1.74,
p > 0.05); tertiary education
and long SP (>55 days) (RRR
1.30, 95 % CI: 0.55-3.08,
p > 0.05)
Medium
Quaife et al. (2014) [32] Hypothetical
Quantitative
6965 men
(n = 4330) and
women (n = 265).
Aged 50 and over
UK All Education K: Recognition (best for
‘lump’)
PB: Poor access health
services
SP: Would wait 2+ weeks:
(cough, n = 48.1 %; breast
change, n = 8.2 %; rectal
bleeding, n = 7.4 %)
K: Lower education
associated with lower
recognition for all 3
symptoms (x2, p < 0.05**)
PB: NR
SP: Lower education
associated with shorter time
to SP for cough (OR 0.61,
95 % CI: 0.54-0.68, p < 0.001)
and breast changes (OR 0.68,
95 % CI: 0.52-0.89, p < 0.001).
NS association with
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education and time to SP for
rectal bleeding (OR 0.83, 95
% CI: 0.67-1.03, p > 0.05)
Rauscher et al. (2010) [66] Retrospective
Quantitative
438 women. Age
range: 30 to 79
years
US Breast Education,
household
income, health
insurance
status
K: Breast lump
misconceptions (20 %
reported one or more
misconception)
PB: Poor general health
service utilisation
SP: Waited over 3 months to
seek medical help (16 %)
K: Lower income and
education associated with
more breast lump
misconceptions (x2, p< 0.001**)
PB: NR
SP: Longer time to SP
associated with lower
education (x2, p< 0.05**) and
lower income
(x2, p< 0.05**)
Medium
Richard et al. (2000) [77] Retrospective
Quantitative
590 men (n = 250)
and women
(n = 340). Mean
age: 51.2 years
France Melanoma Residence,
social level,
education
K: Symptom interpretation
(‘not serious’, 34.8 %)
B: Fear
PB: No symptoms, competing
life priorities (work and family
commitments), melanoma
not detected by participant
PF: Active encouragement
from family
SP: Sought medical help
within 2 months (51.9 %)
K: NS
B: NS
PB: Those with higher
education more likely to
self-detect melanoma
(x2, p < 0.01**)
PF: NR
SP: NS association with and
time to SP and socioeconomic
group (statistics NR)
Medium
Rozniatowski et al. (2005) [73] Retrospective
Quantitative
100 men (n = 84)
and women
(n = 16). Mean
age: 57 years
France Head and
Neck
Education,
occupation
PB: Low anxiety, poor general
health service utilisation
PF: Symptom disclosure,
active encouragement from
partner to seek help
SP: The majority of patients
waited over 1 week to seek
medical help
K: NR
PB: NR
SP: NS association between
socioeconomic group and
time to SP (statistics NR)
Medium
Ristvedt et al. (2014) [33] Retrospective
Quantitative
112 men (n = 55)
and women
(n = 57). Mean
age: 59.3 years
US Colorectal Income, area
of residence,
education,
health
insurance
K: Symptom interpretation
(70.5 % thought symptom
serious within 13 weeks
post onset)
SP: Median time to symptom
presentation (10 weeks)
K: NR
SP: NS association between
socioeconomic group
(education and household
income) and time to SP
(statistics NR)
Medium
Ristvedt and Trinkhaus
(2005) [9]
Retrospective
Quantitative
69 men (n = 42)
and women
(n = 27). Mean
age: 61.3 years
US Colorectal Education K: Symptom interpretation
(‘not cancer’, 71 %)
PB: Personality (low trait
anxiety), poor health service
utilisation
SP: Mean time to symptom
presentation (25 weeks)
K: NR
PB: NR
SP: Lower education
associated with longer time
to SP (Kaplan-Meier: median
15 weeks, 95 % CI: 9.0-26.0*);
higher education associated
with shorter time to SP
(Kaplan-Meier: median 8
weeks, 95 % CI: 4.0-15.0*)
Medium
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Robb et al. (2009) [19] Hypothetical
Quantitative
2216 men
(n = 968) and
women (n = 1240)
UK All Education,
occupation
K: Recall (poor, mean = 2.2)
and recognition (good,
mean = 7.2)
PB: Emotional and service
barriers most endorsed
SP: Most would seek medical
help within 2 weeks
K: Higher socioeconomic
group (occupation)
associated with highest
knowledge (F (2,2015) =
20.31, p < 0.001)
PB: Lower socioeconomic
group (occupation)
associated with more
emotional barriers endorsed:
‘worry what the doctor might
find’ (x2 (1,1989) = 17.08,
p < 0.001), ‘too embarrassed’
(x2 (1,1993) = 20.74, p < 0.001),
‘not confident to talk about
symptom’ (x2 (1,1992) = 4.77,
p < 0.05), NS association with
‘too scared’ (x2 (1,1977) = 1.82,
p > 0.05); Higher
socioeconomic group
(occupation) associated with
more practical barriers
endorsed: ‘too busy’
(x2 (1,2005) = 59.0, p < 0.001),
‘other things to worry about’
(x2(1,1996) = 15.34, p < 0.001),
‘difficult to arrange transport’
(x2(1,2010) = 11.13, p < 0.001);
NS association between
socioeconomic group
(occupation) and service
barriers: ‘difficult to make
appointment’ (x2 (1,1983) =
0.41, p > 0.05), ‘worried about
wasting the doctors time’ (x2
(1,1995) = 1.44, p > 0.05),
‘difficult to arrange transport’
(x2 (1,1938) = 1.15, p > 0.05)
SP: Lower socioeconomic
group (occupation)
associated with shorter time
to SP for unexplained
bleeding (x2 (1,1991) = 5.82, p
< 0.01), difficulty swallowing
(x2 (1,1987) = 28.41, p < 0.001),
lump (x2(1,1988) = 21.26,
p < 0.001), change in mole (x2
(1,1967) = 24.24, p < 0.001),
unexplained pain (x2(1,1965) =
20.24, p < 0.001), sore that
does not heal (x2 (1,1977) =
35.84, p < 0.001), change in
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bowel/bladder habits (x2
(1,1982) = 56.87, p < 0.001),
cough (x2 (1,1984) = 48.32,
p < 0.001), unexplained weight
loss (x2 (1,1963) = 77.73,
p < 0.001)
Samet et al. (1988) [62] Retrospective
Quantitative
800 men (n = 396)
and women
(n = 404). Mean
age: 72.2 years
US All Education,
income
PB: Poor general health
service utilisation, poor
access
SP: Most sought medical help
within 2 months
PB: NR
SP: Longer time to SP
associated with lower income
for breast and colorectal
cancer (x2, p < 0.05**) and
lower education for all
tumour sites (x2, p < 0.05**)
Medium
Schmid-Wendter (2002) [40] Retrospective
Quantitative
233 men (n = 109)
and women
(n = 109). Mean
age: 54.5 years
Germany Melanoma Education K: Previous knowledge of
melanoma, symptom
interpretation
B: Fear
PB: Lesion not visible, too
busy
SP: Sought medical help
within 1 month (15.5 %)
K: Higher education more
likely to have knowledge
about melanoma
(x2, p < 0.001**)
B: NR
PB: NR
SP: NR
Medium
Siminoff et al. (2014) [35] Retrospective
Mixed methods
252 men (n = 132)
and women
(n = 120). Mean
age: 58 years
(range 25 to 94
years)
US Colorectal Education,
Employment,
Income
K: Symptom interpretation
(39.7 % did not think
symptom was serious)
PB: Financial barriers (28.6 %),
fear of diagnostic tests
(24.3 %), embarrassment
(11.9 %)
SP: Mean appraisal delay
(4.8 months)
K: NR
PB: NR
SP: NS association between
time to SP and
socioeconomic group
(statistics NR)
Medium
Simon et al. (2010) [49] Retrospective
Quantitative
236 men (n = 968)
and women
(n = 1240). 11.4 %
(n = 236) had
experienced a
symptom in the
past 3 months
UK All Occupation K: Recognition (better
knowledge if experienced a
symptom previously);
symptom interpretation
(worry symptom might be
cancer)
PB: Emotional and practical
barriers
SP: Symptom experience:
11.4 % experienced symptom
in past 3 months (75 %
consulted a GP about
symptom)
K: NS association between
symptom interpretation and
socioeconomic group
(statistics NR)
PB: NR
SP: NS association between
SP and socioeconomic group
(statistics NR)
Good
Smith and Anderson
(1985) [51]
Retrospective
Quantitative
82 women. Age
range: 20 to 54
years
US Ovarian Income,
education,
occupation
K: Symptom interpretation
(‘cancer’, 10 %)
B: Fear
PB: Previous benign diagnosis
SP: Median time to symptom
presentation (4 weeks)
K: NS association between
symptom interpretation and
socioeconomic group
(statistics NR)
B: NR
Medium
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PB: NR
SP: NR
Temoshok et al. (1983) [75] Retrospective
Quantitative
106 men and
women. Age
range: 18 to
72 years.
US Melanoma Education,
occupation
K: Previous knowledge of
melanoma
B: Melanoma not a serious
disease
PF: Lesion visible (face and
neck)
SP: Mean time to symptom
presentation (4 months)
K: No association with
knowledge and occupation
(statistics NR)
B: NR
PF: NR
SP: No association with time
to SP and occupation
(statistics NR)
Poor
Tod et al. (2008) [80] Retrospective
Qualitative
20 men (n = 12)
and women
(n = 8).
UK Lung Occupation K: Symptom interpretation
(poor, symptoms usually
interpreted as acute
conditions)
B: Fear, fatalism
PB: If previously given up
smoking (thought risk of lung
cancer was nil), worry about
the wasting doctors time,
previous bad experiences
with health system, blame,
stigma, stoicism, poor health
service utilisation
PF: Active encouragement
from family member
SP: Range in time to
symptom presentation
(0 to 24 months)
Good
Tomlinson et al. (2012) [60] Retrospective
Quantitative
87 men (n = 56)
and women
(n = 31). Mean
age: 65 years.
Canada Colorectal Education K: Symptom interpretation
PB: Self medication
SP: Waited over 1 month to
seek medical help (51 %)
K: NR
PB: NR
SP: NS association between
education and time to SP
(x2, p > 0.05**)
Medium
Trivers et al. (2011) [52] Hypothetical
Quantitative
2991 women.
65 % were aged
45 years and over.
US Gynaeco-
logical
Education,
Income
B: Concern about developing
gynaecological cancer
PB: Being premenopausal
SP: 50 % of women would
seek help for most symptoms
B: NR
PB: NR
SP: NS association between
SP intentions and
socioeconomic group
(statistics NR)
Medium
Van Osch et al. (2007) [48] Hypothetical
Quantitative
459 men (49 %)
and women
(51 %) over the
age of 55. Mean
age: 68.6 years.
Netherlands All Education K: Recognition (low to
moderate, mean: 6.2)
B: Benefits of early detection
SP: Fair. Inconsistent for
urgent symptoms, good for
prolonged symptoms
K: NR
B: NR
SP: Lower education
associated with shorter time
to SP (F (2,436) =6.084,
p < 0.01)
Good
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Waller et al. (2009) [53] Hypothetical
Quantitative
1500 men and
women from
various ethnic
minority groups.
England All Occupation K: Recall (poor, mean: 1.2)
and recognition (poor,
mean: 4.7)
PB: Worry what doctor might
find (most endorsed)
SP: African and Caribbean
groups anticipated fastest
time to symptom
presentation
K: Higher socioeconomic
group associated with higher
recall (F(1,1487) = 6.12, p <
0.01) and higher recognition
(F (1,1487) = 5.45, p < 0.05)
PB: NR
SP: NR
Good
Walter et al. (2014) [41] Retrospective
Qualitative
63 men (n = 31)
and women
(n = 32). Age
range: 29-93 years.
UK Melanoma Education K: Symptom attributions
(initially attributed to benign
skin conditions or normal
life changes)
PB: Worry about wasting the
doctors time, service barriers,
competing life priorities,
reassurance following
symptom disclosure
PF: Family history of
melanoma, perceptions of
high risk, symptom
disclosure, symptom noticed
by another person
SP: Range 1-303 weeks
Good
Whitaker et al. (2014) [55] Retrospective
Quantitative
1724 men
(n = 789) and
women (n = 921)
over the age of
50. Mean age:
64.4 years.
England All Postcode,
education,
employment
K: Symptom interpretations
(2 % thought symptom was
cancer, highest interpretation
for ‘unexplained lump’),
perceived seriousness of
symptoms
SP: Symptom experience
(53 % experienced at least 1
symptom in past 3 months).
59 % contacted GP about
symptom
K: Unemployment associated
with higher perceived
seriousness of pain (OR 2.26,
95 % CI: 1.17-4.35, p < 0.05),
tiredness (OR 2.11, 95 %
CI:1.23-3.64, p < 0.05), sore
throat (OR 3.56, 95 % CI:
1.10-11.45, p < 0.05) and
chest pain (OR 3.56, 95 % CI:
1.10-11.45, p < 0.05). Lower
education associated with
higher perceived seriousness
cough (OR 2.25, 95 % CI:
1.10-4.56, p < 0.05), tiredness
(OR 2.46, 95 % CI:1.44-4.21,
p < 0.05), headaches (OR 3.80,
95 % CI: 1.63-8.89, p < 0.05),
shortness of breath (OR 2.34,
95 % CI: 1.11-4.97, p < 0.05),
sore throat (OR 4.16, 95 % CI:
1.14-15.22, p < 0.05) and
chest pain (OR 4.16, 95 % CI:
1.13-15.22, p < 0.05)
SP: NR
Good
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Whitaker et al. (2015) [81] Retrospective
Qualitative
48 men (n = 23)
and women
(n = 25) over the
age of 50. Mean
age: 64.4 years.
England All Education,
employment
K: Symptom interpretations
(symptoms normalised or
associated with cancer)
PB: Stoicism, fear of
diagnostic tests, worry about
wasting doctors time, service
barriers, negative attitudes
towards HCPs, medical
mistrust
PF: Development of new
symptoms, persistence of
symptoms, symptom
disclosure, fear
SP: Varied per symptom:
33.3 % contacted GP with
‘persistent cough’, 100 %
contacted GP with
‘unexplained bleeding’
Good
K = cancer symptom knowledge; B = beliefs about cancer; PB = perceived barriers to symptom presentation; PF = perceived facilitators to symptom presentation; SP = time to symptom presentation; NR = not reported;
NS = not significant; *p-value not reported; **other statistics not reported
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Studies which measured actual time to symptom pres-
entation reported the longest delays in symptom presen-
tation among individuals with lower educational
attainment [33, 34, 42, 54, 58–61], lower annual income
[61, 62], lower occupation and employment [43, 61, 63]
and those from deprived areas [64]. This effect was also
observed in studies of actual symptom presentation
where multiple socioeconomic indices were reported
[34, 42, 44, 61, 65, 66]. Twenty-two studies found no
group differences for socioeconomic group indicators
and time to symptom presentation [30, 33, 35–37, 45,
46, 49, 50, 52, 60, 67–77].
Knowledge
Knowledge of symptoms based on recall methods was
generally lower than in studies that used recognition
methods. Lump symptoms were the most recalled and
well-recognised potential cancer symptom [19, 32, 48,
50, 53, 56, 64, 78]. This was supported by retrospective
studies where patients presenting with a lump were most
likely to have attributed their lump symptom to cancer
[39, 43, 45, 74, 79]. Knowledge was generally poor for
non-specific symptoms of cancer. Symptoms such as fa-
tigue or unexplained weight loss were poorly recalled or
recognised as potential symptoms of cancer [28, 29, 31,
53, 78]. Poorer cancer symptom knowledge was associ-
ated with lower socioeconomic group when measured
by educational attainment [28, 32, 40, 50, 54, 56], occu-
pation [53] and multiple indicators [19, 28, 66]. These
findings were consistent across site-specific and non
site-specific studies, suggesting poor general cancer
symptom knowledge in lower socioeconomic groups re-
gardless of cancer type.
In retrospective studies, patients experiencing non-
specific symptoms recalled attributing them to other
benign causes or life stresses [35, 51, 55, 65, 69, 76,
80, 81] or not recognising the seriousness of their
symptoms [9, 33, 35, 37, 40, 42, 43, 45, 47, 51, 54,
55, 57, 60, 65, 68, 76, 77, 81, 82] resulting in patients
delaying symptom presentation [35, 39, 51, 76] or
later stage at diagnosis [69].
Beliefs about cancer
In most studies, beliefs were formed from participants’
past experiences of cancer, usually witnessing friends or
family with the disease [36, 43, 47, 59, 78, 79]. Positive
beliefs were identified in nine studies [30, 36, 43, 48, 54,
58, 78, 79] and tended to focus on the effectiveness of
modern cancer treatments, where participants expressed
trust in doctors and the medical system and endorsed
the benefits of early diagnosis [30, 58, 59, 78] or ac-
knowledged that cancer can be cured [78]. Such beliefs
tended to encourage timely symptom presentation to a
primary care physician [30, 58, 59, 78, 79]. One study
found that those with lower educational attainment were
less likely to endorse positive beliefs about the benefits
of early detection [54].
Negative beliefs tended to manifest in fear or fatalism
regarding cancer. Fear was frequently reported across all
studies examining beliefs. This included fear of diagnosis
[34, 39, 58, 63, 74, 80, 81, 83], fear of treatment [30, 43,
57–59, 68, 78, 83] and fear of dying [59, 78, 83]. Fatalis-
tic beliefs were a common theme throughout studies,
but were expressed only by a minority of participants
per study [34, 36, 42, 56, 59, 61, 78, 79, 84]. Fearful and
fatalistic beliefs about cancer were more likely to be
expressed by individuals from lower socioeconomic
groups based on educational attainment [36, 50] or mul-
tiple indices [42, 71].
When considering time to symptom presentation,
fearful beliefs about cancer appeared to operate at the
two extremes of immediate or prolonged symptom
presentation. For participants whose fearful beliefs
encouraged immediate (actual or hypothetical) presen-
tation to doctors [43, 45, 58, 59, 61, 74, 78, 79, 84], a
visit to doctors was used to alleviate anxiety associ-
ated with the symptom [43, 47, 58, 59, 61, 77, 78].
This was usually coupled with the participant express-
ing trust in the medical profession and positive beliefs
surrounding early diagnosis [43, 59].
For individuals whose fearful beliefs led to prolonged
delays (sometimes years) [30, 34, 38, 39, 43, 47, 51, 61,
68, 74, 78, 79], denial of or ignoring symptoms initially
alleviated anxiety associated with the symptom [38, 39,
47, 59, 68, 72, 76, 78, 79]. Such beliefs were usually
combined with fatalistic beliefs such as ‘cancer cannot be
cured’ [59, 61, 79], and were associated with the longest
times to symptom presentation or were expressed by
those with advanced stage disease [36, 56, 59, 84].
This is likely to reflect a lack of perceived benefit in
presenting to doctors due to the belief that ‘nothing
can be done’ [59, 78].
Barriers to symptom presentation
Some participants reported service barriers relating to
concerns about wasting doctors’ time [19, 29, 31, 34, 41,
43, 55, 80, 81], lack of continuity with primary care doc-
tor [42, 81] or difficulties with accessing and making an
appointment [29, 32, 34, 38, 53, 55, 56, 65, 78, 81]. For
others, practical barriers such as being ‘too busy to make
an appointment’ were reported and these delayed symp-
tom presentation [31, 39, 40, 43, 49, 74, 77, 78]. Low
general health service utilisation for acute or long term
conditions lengthened time to cancer symptom pres-
entation [9, 34, 42, 43, 57, 58, 61, 66, 68, 73, 77, 78,
80, 84]. Emotional barriers included embarrassment
or fear associated with undergoing intimate diagnostic
tests [19, 29, 31, 34, 35, 49, 57, 78, 81].
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Practical barriers such as ‘being too busy’ were more
frequently reported in high socioeconomic groups [19].
In countries where patients pay for their healthcare,
those with lower annual income were more likely to re-
port the cost of a consultation as a barrier to symptom-
atic presentation [38, 63].
Facilitators to symptom presentation
The most common facilitator of symptom presentation
was disclosure of symptoms to a family member or
friend [34, 39, 41, 43, 45, 47, 55, 61, 65, 70, 73, 76–79,
81, 84, 85]. In some cases, this reduced time to symptom
presentation by half [36] or by six times [45]. The ap-
pearance of a new symptom [43, 69, 76, 83] or persist-
ence of the current symptom [45, 69, 76, 81, 84]
facilitated decisions to seek medical help. One study
found that individuals from a lower socioeconomic
group who disclosed their symptom to a family member
or friend took longer to seek medical help compared to
those from a higher socioeconomic group [65]. In five
studies, participants waited until they developed another
health complaint or tagged their cancer symptom on
to the end of a consultation which provided an
opportunity to disclose the cancer symptom during
the consultation [42, 45, 68, 81, 82].
Discussion
This review is the first to systematically explore how
knowledge, beliefs and barriers/facilitators to symptom
presentation affect actual or anticipated cancer symptom
presentation in relation to socioeconomic group, across
all tumour sites. Poor knowledge of non-specific cancer
symptoms such as fatigue and weight loss prolonged
presentation due to misattribution of symptoms in lower
socioeconomic groups. In contrast, lump and bleeding
symptoms were most frequently recalled, recognised and
prompted the fastest symptom presentation. A know-
ledge gradient was observed, where poorer cancer
symptom knowledge was associated with lower socio-
economic group based on multiple indices. There was
some evidence to suggest that those from a lower socio-
economic group were more likely to hold fearful and fa-
talistic beliefs about cancer and less likely to endorse
positive beliefs about the benefits of early diagnosis.
Such combinations of fearful and fatalistic beliefs were
associated with prolonged symptom presentation. In
addition, emotional barriers to symptom presentation
such as worry what the doctor might find were more
likely to be endorsed in lower socioeconomic groups.
Such poor knowledge and prevalent beliefs might ac-
count for the long actual delays and later stage cancers
diagnosed in lower socioeconomic groups. Disclosure of
a symptom to a family member or friend was a key
facilitator in the decision to seek medical help, although
there was some evidence to suggest that symptom
disclosure acted as a barrier in lower socioeconomic
groups.
Most included studies were of medium quality. In
many studies, socioeconomic group was measured but
not reported for all outcome variables. Most studies only
reported socioeconomic group differences for symptom
presentation. Twenty-three studies reported socioeco-
nomic group differences for the other outcome mea-
sures: knowledge, beliefs and barriers/facilitators to
symptom presentation. A further eight studies could
have met the inclusion criteria, but were excluded due
to non-reporting of any outcomes associated with socio-
economic group [14, 86-92]. Methodological limitations
included a long duration between cancer diagnosis and
participation in retrospective studies, and samples biased
towards higher socioeconomic groups. In some studies,
socioeconomic variation was insufficient to perform stat-
istical analysis on all outcomes.
There are methodological limitations associated with
retrospective (actual symptom presentation) and hypo-
thetical (anticipated symptom presentation) designs.
Whilst retrospective studies are affected by recall bias,
hypothetical studies rely on intentions which may not
translate into actual presentation behaviour [93]. This
was observed in the variation between actual and hypo-
thetical time to symptom presentation, where partici-
pants anticipated prompt symptom presentation but in
reality reported longer delays. Study designs exploring
actual symptom presentation behaviour in a population
sample are likely to reduce some of the limitations asso-
ciated with retrospective and hypothetical symptom
presentation study designs. In such study designs, partic-
ipants disclose actual symptoms experienced in the past
three months, usually prompted by a list (without any
mention of cancer), and reasons for not consulting a
doctor are explored [49, 54, 55, 81].
The limitations of this review include problems relat-
ing to retrieval of studies and analysis of the evidence.
Due to poor indexing of studies in this topic area under
the MeSH indexing in this topic area, a high proportion
of studies (n = 11) was found through hand-searching.
Additionally, meta-analysis was precluded by the wide
range of qualitative and quantitative data collection
methods of included studies. Finally, other factors such
as age, gender and ethnicity can affect symptom presen-
tation [6, 18]; however, interactions between these
variables and socioeconomic group were not addressed
in the current review.
The findings of the current review confirm that failure
to appreciate the seriousness of symptoms [6, 16] and
non-disclosure of symptoms [6, 15] lengthened time to
symptom presentation. Our findings accord with previ-
ous studies in which negative beliefs [20], longer time to
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actual symptom presentation [6] and low suspicion for
cancer symptoms [94] were associated with low socio-
economic group [6]. The current findings support
Mitchell et al.’s (2008) [16] review of colorectal cancer
patients, in which fear of cancer either lengthened or
shortened time to symptom presentation. Such findings
might be explained by Type I and Type II information
processing systems. Type I processing is a fast and auto-
matic system, which represents an individual’s ‘gut
reaction’ to an event, whereas Type II is a slower, more
thoughtful and deliberative system [95]. Whilst most
people initially experience fear in reaction to a worrying
symptom (Type I processing), cognitions during Type II
processing may influence the decision to seek medical
help since these are slower and may help someone to ra-
tionalise the situation [96]. If an individual has had time
to consider the benefits of seeking medical help, and
based upon their previous beliefs about early diagnosis,
such beliefs may override the Type 1 fear response. We
found evidence to suggest a higher prevalence of fearful
and fatalistic beliefs in lower socioeconomic groups and
some evidence for fewer positive beliefs surrounding the
benefits of early diagnosis in lower socioeconomic
groups. This suggests that Type I beliefs may not be
overridden by Type 2 responses relating to the benefits
of early diagnosis due to lower knowledge or higher
emotive responses. As a consequence this may delay
symptom presentation. Findings relating to symptom
disclosure suggest that people use the ‘lay system’ of
healthcare (consulting family and friends) before making
the decision to access formal healthcare [13, 97, 98].
However, among individuals from low socioeconomic
groups, disclosing symptoms to someone with equally
poor knowledge and Type I negative automatic beliefs
about cancer may encourage false reassurance in the be-
nign nature of symptoms and consequently no urgency
to seek medical help.
Cancer awareness interventions should be carefully de-
veloped to target those who are most likely to present
with advanced stage disease: lower socioeconomic
groups with low symptom knowledge and fearful and
fatalistic beliefs about cancer. Such an intervention
should utilise an individual’s social networks to facili-
tate distribution of information [97], highlighting the
significance of non-lump symptoms as potentially in-
dicative of cancer, along with advice on an appropri-
ate time in which an individual should seek medical
help and how to access such help [99]. This should
be coupled with information outlining the benefits of
early diagnosis and improved effectiveness of modern
treatments for cancer, countering negative beliefs sur-
rounding cancer. Future research should evaluate the
effectiveness of such interventions in lower socioeco-
nomic groups.
Conclusion
Knowledge of potential cancer symptoms, beliefs about
cancer and barriers to symptom presentation work in
combination to influence symptom presentation: know-
ledge is necessary for accurate symptom appraisal, but
beliefs about cancer and barriers to symptom presenta-
tion influence the decision to seek medical help or not.
This is especially important in the context of socioeco-
nomic deprivation, where lower knowledge, higher nega-
tive beliefs about cancer and perceived barriers may lead
to avoidable delays, later stage of diagnosis and ultim-
ately poorer survival outcomes. Targeted interventions
should not only educate people about symptoms for
cancer, but also work to break down unhelpful myths
surrounding cancer survival and treatment options.
They should address the barriers that people in lower
socio-economic groups experience, and use social net-
works to raise awareness and support early symptom
presentation.
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